United Kingdom · Question · Written question
UIN 66392
Cancer: Medical Treatments
Original
Introduced
9 July 2025
Last action
15 July 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 July 2025
Summary
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) representatives of the pharmaceutical industry, (b) the NHS, (c) Cabinet colleagues and (d) other stakeholders on indication-specific pricing of medications use
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 July 2025
Written question
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) representatives of the pharmaceutical industry, (b) the NHS, (c) Cabinet colleagues and (d) other stakeholders on indication-specific pricing of medications use
Source: Commons
15 July 2025
Answer
My Rt Hon. Friend, the Secretary of State for Health and Social Care has not held any meetings specifically on the topic of indication-specific pricing of medications used in the treatment of more than one form of cancer.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-07-09/66392
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1821391
- uk · wq-1821391 · source updated 15 July 2025